Clinical Trial Update: A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study of suvecaltamide in adults with residual tremor associated with Parkinson's disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Suvecaltamide (suvecaltamide)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Parkinson Disease, Tremor | Phase 2 | Status: COMPLETED | Results posted: 2026-01-15